Perianal Basal Cell Carcinoma Successfully Managed with Excisional Biopsy

Basal cell carcinoma (BCC) is the most common cutaneous malignancy in the United States and is often nonaggressive. Its location in the perianal region is very rare and it is estimated that only 0.08% of all BCCs occur in this region. Herein, we present a case of perianal basal cell carcinoma, nodul...

Full description

Saved in:
Bibliographic Details
Main Authors: Paola C. Aldana, Harris G. Yfantis, Preeti R. John
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Case Reports in Dermatological Medicine
Online Access:http://dx.doi.org/10.1155/2019/6268354
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561661457727488
author Paola C. Aldana
Harris G. Yfantis
Preeti R. John
author_facet Paola C. Aldana
Harris G. Yfantis
Preeti R. John
author_sort Paola C. Aldana
collection DOAJ
description Basal cell carcinoma (BCC) is the most common cutaneous malignancy in the United States and is often nonaggressive. Its location in the perianal region is very rare and it is estimated that only 0.08% of all BCCs occur in this region. Herein, we present a case of perianal basal cell carcinoma, nodular type. The diagnosis was made using excisional biopsy of a skin lesion. Immunohistochemical staining confirmed the diagnosis: it showed diffuse and strong positivity for smooth muscle actin (SMA) and monoclonal antibody BER-Ep4 and was negative for carcinoembryonic antigen (CEA), pancytokeratin (AE1/AE3), and epithelial membrane antigen (EMA). The treatment of choice has traditionally been local excision to clear margins but the newest guidelines recommend Mohs Micrographic surgery (MMS) or standard 4mm surgical margins for this high-risk BCC. Our patient was successfully treated using excisional biopsy without recurrence. In select patients with lesions smaller than 1cm, excisional biopsy may be sufficient to treat the disease and may be better tolerated than MMS and wider surgical margins. Literature review suggests a predisposition for perianal BCC in individuals susceptible to cutaneous malignancies. Therefore, any history of cutaneous malignancy should further prompt clinicians to examine nonsun exposed areas on full body skin exams.
format Article
id doaj-art-bcb11bf744694b559182e458437beb25
institution Kabale University
issn 2090-6463
2090-6471
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Case Reports in Dermatological Medicine
spelling doaj-art-bcb11bf744694b559182e458437beb252025-02-03T01:24:32ZengWileyCase Reports in Dermatological Medicine2090-64632090-64712019-01-01201910.1155/2019/62683546268354Perianal Basal Cell Carcinoma Successfully Managed with Excisional BiopsyPaola C. Aldana0Harris G. Yfantis1Preeti R. John2University of Maryland School of Medicine, Baltimore, MD, USAUniversity of Maryland School of Medicine, Baltimore, MD, USAUniversity of Maryland School of Medicine, Baltimore, MD, USABasal cell carcinoma (BCC) is the most common cutaneous malignancy in the United States and is often nonaggressive. Its location in the perianal region is very rare and it is estimated that only 0.08% of all BCCs occur in this region. Herein, we present a case of perianal basal cell carcinoma, nodular type. The diagnosis was made using excisional biopsy of a skin lesion. Immunohistochemical staining confirmed the diagnosis: it showed diffuse and strong positivity for smooth muscle actin (SMA) and monoclonal antibody BER-Ep4 and was negative for carcinoembryonic antigen (CEA), pancytokeratin (AE1/AE3), and epithelial membrane antigen (EMA). The treatment of choice has traditionally been local excision to clear margins but the newest guidelines recommend Mohs Micrographic surgery (MMS) or standard 4mm surgical margins for this high-risk BCC. Our patient was successfully treated using excisional biopsy without recurrence. In select patients with lesions smaller than 1cm, excisional biopsy may be sufficient to treat the disease and may be better tolerated than MMS and wider surgical margins. Literature review suggests a predisposition for perianal BCC in individuals susceptible to cutaneous malignancies. Therefore, any history of cutaneous malignancy should further prompt clinicians to examine nonsun exposed areas on full body skin exams.http://dx.doi.org/10.1155/2019/6268354
spellingShingle Paola C. Aldana
Harris G. Yfantis
Preeti R. John
Perianal Basal Cell Carcinoma Successfully Managed with Excisional Biopsy
Case Reports in Dermatological Medicine
title Perianal Basal Cell Carcinoma Successfully Managed with Excisional Biopsy
title_full Perianal Basal Cell Carcinoma Successfully Managed with Excisional Biopsy
title_fullStr Perianal Basal Cell Carcinoma Successfully Managed with Excisional Biopsy
title_full_unstemmed Perianal Basal Cell Carcinoma Successfully Managed with Excisional Biopsy
title_short Perianal Basal Cell Carcinoma Successfully Managed with Excisional Biopsy
title_sort perianal basal cell carcinoma successfully managed with excisional biopsy
url http://dx.doi.org/10.1155/2019/6268354
work_keys_str_mv AT paolacaldana perianalbasalcellcarcinomasuccessfullymanagedwithexcisionalbiopsy
AT harrisgyfantis perianalbasalcellcarcinomasuccessfullymanagedwithexcisionalbiopsy
AT preetirjohn perianalbasalcellcarcinomasuccessfullymanagedwithexcisionalbiopsy